Compound class:
Synthetic organic
Comment: 14l is reported as a selective TYK2 inhibitor [2]. It was developed to investigate the anti-inflammatory potential of selective TYK2 inhibition.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
14l exhibits biochemical selectivity over the other three homologous JAK kinases, as well as good functional potency as measured as JAK/STAT pathway-mediated effects on lymphocyte cell lines and human whole blood [1]. In a kinome screen serine/threonine kinase-16 (STK16) was the only significant off-target (inhibited by >75% at 100 nM inhibitor). |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|